Home › Funds › Kohlberg Kravis Roberts & Co. L.P. › COGT

Kohlberg Kravis Roberts & Co. L.P. position in COGT

COGENT BIOSCIENCES INC · Health Care

Kohlberg Kravis Roberts & Co. L.P. reported holding 500,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$548K, representing 0.01% of its reported portfolio and ranking #48 among its reported holdings. Kohlberg Kravis Roberts & Co. L.P. has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)500.00K sh
Reported value held$547.95K
Portfolio Weight0.01%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kohlberg Kravis Roberts & Co. L.P.'s COGT position evolved

Kohlberg Kravis Roberts & Co. L.P. first disclosed a stake in COGT in Q4 2025 at 990,000 shares (US$1.2M). The position peaked in Q2 2026 at 990,000 shares, worth US$1.2M. Across 4 filings, Kohlberg Kravis Roberts & Co. L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 500,000 shares valued at US$548K — a reduction of -490,000 shares quarter over quarter.. Notable position changes include a 49% trim in Q3 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 990.00K $1.16M New
Q1 2026 990.00K $1.21M Hold
Q2 2026 990.00K $1.23M Hold
Q3 2026 500.00K $547.95K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 56 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Kohlberg Kravis Roberts & Co. L.P. held COGT?

Kohlberg Kravis Roberts & Co. L.P. has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Kohlberg Kravis Roberts & Co. L.P.'s current position in COGT?

As of Q3 2026, Kohlberg Kravis Roberts & Co. L.P. holds 500.00K shares of COGT (COGENT BIOSCIENCES INC), valued at $547.95K, representing 0.01% of its reported portfolio and ranking #48.

Has Kohlberg Kravis Roberts & Co. L.P. been buying or selling COGT?

In the latest 13F filing (Q3 2026), Kohlberg Kravis Roberts & Co. L.P. reduced its position in COGT. The position peaked in Q2 2026 at 990.00K shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.